iShares Health Innovation Active ETF (BMED)

Assets	$10.53M
Expense Ratio	0.55%
PE Ratio	23.49
Shares Out	360,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,353
Open	29.02
Previous Close	29.24
Day's Range	28.82 - 29.02
52-Week Low	20.57
52-Week High	32.19
Beta	0.84
Holdings	53
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

45.65% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	7.79%
Merck & Co., Inc.	MRK	5.62%
Gilead Sciences, Inc.	GILD	5.52%
BLK CSH FND TREASURY SL AGENCY	XTSLA	5.51%
Amgen Inc.	AMGN	4.45%
Edwards Lifesciences Corporation	EW	4.22%
WuXi Biologics (Cayman) Inc.	2269	3.21%
Biogen Inc.	BIIB	3.20%
Waters Corporation	WAT	3.07%
Mettler-Toledo International Inc.	MTD	3.06%

Performance

BMED had a total return of 26.25% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.22%.